The Better Menopause Has Funded Clinical Trial
The company is investing in research to study the effectiveness of its Better Metabolism supplement.
Updated on Sept. 22, 2026 in Weight Loss
Live Poll
Do you trust that health supplements marketed for menopause provide real, verified medical benefits?
The Better Menopause has announced a £100,000 investment to conduct a clinical trial for its Better Metabolism supplement. This randomized, double blind, placebo controlled study aims to provide scientific backing for its product line.
Why it matters
The investment seeks to address a significant lack of robust scientific evidence currently found in the broader women's health supplement market. By conducting controlled research, the company hopes to validate the specific benefits of its health offerings.
The clinical trial is supported by a £100,000 investment and will track participants over a 12-week intervention period. Researchers from the University of Southampton will monitor blood and urine biomarkers to evaluate the results.
The players
The Better Menopause
This health company operates internationally with sales in the UK, Ireland, US, Australia, and Canada.
University of Southampton
This academic institution is providing the researchers who will conduct the clinical trial.
Joanna Lyall
She is one of the co-founders of The Better Menopause.
Debbie Wosskow
She serves as a co-founder of The Better Menopause.
The details
The study involves 80-90 women currently in menopause who will participate in a 12-week intervention. Researchers will analyze data collected at the beginning and end of the trial to determine the impact of the supplement on metabolism.
Timeline
The Better Menopause launched in the UK in July 2023.
Clinical study results are expected to be published next year.
The company plans two new product launches for early 2027.
The Big Picture
This trial follows the rigorous standards set by the University of Southampton to bridge the evidence gap in consumer health products. It reflects a growing industry trend of moving supplement claims from anecdotal marketing toward peer-reviewed clinical validation.
This research provides consumers with a higher level of transparency regarding the efficacy of products they may already be using for menopause. It allows patients to make better informed decisions about their supplement routines based on verifiable clinical outcomes.
The takeaway
The move signifies a shift toward higher accountability for companies operating in the women's health sector. Consumers should look for published results from such trials before integrating new supplements into their daily wellness plans.
What happens next
The company has announced plans to release two new products in early 2027.
Further reading
For more information on the evolving supplement landscape, visit our Weight Loss section.
Live Poll
Do you trust that health supplements marketed for menopause provide real, verified medical benefits?
